# Standard Versus Transepithelial Corneal Crosslinking

> **NCT02349165** · NA · COMPLETED · sponsor: **Nienke Soeters** · enrollment: 61 (actual)

## Conditions studied

- Keratoconus

## Interventions

- **PROCEDURE:** Transepithelial versus epithelium-off CXL
- **DRUG:** Ricrolin TE
- **DRUG:** Isotonic riboflavin

## Key facts

- **NCT ID:** NCT02349165
- **Lead sponsor:** Nienke Soeters
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2015-01-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02349165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02349165, "Standard Versus Transepithelial Corneal Crosslinking". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02349165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*